Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Change in Inventory (2022 - 2025)

Historic Change in Inventory for Rhythm Pharmaceuticals (RYTM) over the last 4 years, with Q3 2025 value amounting to $2.5 million.

  • Rhythm Pharmaceuticals' Change in Inventory rose 2893.21% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.4 million, marking a year-over-year increase of 2054.46%. This contributed to the annual value of $10.1 million for FY2024, which is 7727.35% up from last year.
  • As of Q3 2025, Rhythm Pharmaceuticals' Change in Inventory stood at $2.5 million, which was up 2893.21% from -$479000.0 recorded in Q2 2025.
  • Rhythm Pharmaceuticals' 5-year Change in Inventory high stood at $4.8 million for Q4 2024, and its period low was -$479000.0 during Q2 2025.
  • For the 4-year period, Rhythm Pharmaceuticals' Change in Inventory averaged around $1.5 million, with its median value being $1.2 million (2022).
  • Per our database at Business Quant, Rhythm Pharmaceuticals' Change in Inventory soared by 3180000.0% in 2023 and then tumbled by 11373.67% in 2025.
  • Quarter analysis of 4 years shows Rhythm Pharmaceuticals' Change in Inventory stood at $1.2 million in 2022, then fell by 29.98% to $862000.0 in 2023, then skyrocketed by 462.18% to $4.8 million in 2024, then crashed by 49.42% to $2.5 million in 2025.
  • Its Change in Inventory stands at $2.5 million for Q3 2025, versus -$479000.0 for Q2 2025 and $575000.0 for Q1 2025.